These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 34420405)
1. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression. Kang J; Huang X; Dong W; Zhu X; Li M; Cui N Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405 [TBL] [Abstract][Full Text] [Related]
2. LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of Ge B; Zhang X; Zhou W; Mo Y; Su ZH; Xu G; Chen Q Cell J; 2022 Jun; 24(6):294-301. PubMed ID: 35892231 [TBL] [Abstract][Full Text] [Related]
4. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7. Gao J; Dai C; Yu X; Yin XB; Zhou F Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis. Mu B; Lv C; Liu Q; Yang H J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950 [TBL] [Abstract][Full Text] [Related]
6. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. Shen HM; Zhang D; Xiao P; Qu B; Sun YF Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524 [TBL] [Abstract][Full Text] [Related]
8. Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS1. Ren X; Shen L; Gao S J Environ Pathol Toxicol Oncol; 2024; 43(1):79-90. PubMed ID: 37824372 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2. Wei W; Huang X; Shen X; Lian J; Chen Y; Wang W; Huang J; Zhang B Crit Rev Eukaryot Gene Expr; 2022; 32(1):1-9. PubMed ID: 35377976 [TBL] [Abstract][Full Text] [Related]
10. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma. Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1. Chen K; Hou Y; Liao R; Li Y; Yang H; Gong J Oncogene; 2021 May; 40(18):3217-3230. PubMed ID: 33824472 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
15. SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression. Xie Y; Wang Y; Gong R; Lin J; Li X; Ma J; Huo L Cancer Biother Radiopharm; 2020 Dec; 35(10):731-740. PubMed ID: 32397799 [No Abstract] [Full Text] [Related]
16. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma. Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q; Zhang W; Wang Z; Liu S BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767 [TBL] [Abstract][Full Text] [Related]
19. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006 [TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1. Lv J; Yu YQ; Li SQ; Luo L; Wang Q Asian Pac J Cancer Prev; 2014; 15(6):2565-70. PubMed ID: 24761865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]